Author:
Bladé J.,San Miguel J.,Alcalá A.,Maldonado J.,García-Conde J.,Moro M. J.,Sanz Sanz M. A.,Alonso C.,Zubizarreta A.,Besses C.,Hernández Martín J. M.,Besalduch J.,Hernández Nieto L.,Fernández Calvo J.,Rubio D.,Mayans J. R.,Sanchis J.,Jimenez Galindo R.,Tortosa J.,Ortega F.,Domingo A.,Faura M. V.,Daniels M.,Rozman C.,Estapé J.
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine,Hematology
Reference24 articles.
1. Abramson N, Lurie P, Mietlowski WL, Schilling A, Bennet J, Horton H (1982) Phase III study of intermittent carnustine (BCNU), cyclophosphamide, and prednisone versus melphalan and prednisone in multiple myeloma. Cancer Treat Rep 66: 1273–1277
2. Alexanian R, Haut A, Khan AU, Lane M, McKelvey EM, Migliore PJ, Stukey WJ, Wilson HE (1969) Treatment for multiple myeloma: combination chemotherapy with different melphalan dose regimens. JAMA 208: 1680–1685
3. Alexanian R, Dreicer R (1984) Chemotherapy for multiple myeloma. Cancer 53: 583–588
4. Bergsagel DE, Bailey AJ, Langley GR, MacDonald RN, White DF, Miller AB (1979) The chemotherapy of plasma cell myeloma and the incidence of acute leukemia. N Engl J Med 301: 743–748
5. Bergsagel DE (1983) Progress in the treatment of plasma cell myeloma? J Clin Oncol 1: 510–512
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献